Stockholm - Delayed Quote SEK
MedCap AB (publ) (MCAP.ST)
416.50
-11.00
(-2.57%)
At close: June 13 at 5:29:36 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,838,900
1,806,800
1,587,400
1,111,400
916,300
Cost of Revenue
763,700
749,600
660,700
434,300
347,700
Gross Profit
1,075,200
1,057,200
926,700
677,100
568,600
Operating Expense
810,400
785,000
699,400
527,900
460,700
Operating Income
264,800
272,200
227,300
149,200
107,900
Net Non Operating Interest Income Expense
-9,400
-10,700
-5,200
-14,100
-9,000
Pretax Income
255,400
261,600
222,300
152,000
117,000
Tax Provision
51,500
52,300
49,800
34,000
18,900
Net Income Common Stockholders
201,900
207,400
172,200
117,600
96,500
Diluted NI Available to Com Stockholders
201,900
207,400
172,200
117,600
96,500
Basic EPS
13.60
--
11.60
7.90
6.50
Diluted EPS
13.60
--
11.60
7.90
6.50
Basic Average Shares
14,860.08
--
14,807.35
14,807.35
14,801.84
Diluted Average Shares
14,860.08
--
14,856.55
14,807.35
14,801.84
Total Operating Income as Reported
264,800
272,300
227,500
170,900
127,000
Total Expenses
1,574,100
1,534,600
1,360,100
962,200
808,400
Net Income from Continuing & Discontinued Operation
201,900
207,400
172,200
117,600
96,500
Normalized Income
201,900
207,400
172,200
106,658.40
83,846.20
Interest Income
9,900
8,300
10,400
2,300
400
Interest Expense
19,300
19,000
15,600
16,400
9,400
Net Interest Income
-9,400
-10,700
-5,200
-14,100
-9,000
EBIT
274,700
280,600
237,900
168,400
126,400
EBITDA
394,300
396,000
342,000
256,200
201,900
Reconciled Cost of Revenue
763,700
749,600
660,700
434,300
347,700
Reconciled Depreciation
119,600
115,400
104,000
87,800
75,500
Net Income from Continuing Operation Net Minority Interest
201,900
207,400
172,200
117,600
96,500
Total Unusual Items Excluding Goodwill
--
--
800
14,100
15,100
Total Unusual Items
--
--
800
14,100
15,100
Normalized EBITDA
394,300
396,000
342,000
242,100
186,800
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
3,158.40
2,446.20
12/31/2021 - 11/9/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade